CPHC
Canterbury Park Holding Corporation
CPHC has lower modeled downside risk, despite its lower overall score.
F
Ford Motor Company
F has a slight edge over CPHC overall, supported by stronger valuation and stronger modeled upside.
CPHC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
CPHC's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
CPHC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.8x | $0.98 | -94% |
| Fair | 17x | $1.66 | -89% |
| Expensive | 60x | $5.98 | -62% |
| Current | 157x | $15.70 | — |
Historical ranges are pointers, not guarantees.
CPHC's PE is in its expensive range at 157x.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
CPHC Forward outlook
There aren't enough analyst estimates for CPHC to show an outlook.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect F's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CPHC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.10 | +$0.37 |
| Q2 2026 | $0.02 | -33% |
| Q1 2026 | -$0.01 | -106% |
| Q4 2025 | -$0.10 | -124% |
| Q3 2025 | -$0.27 | -129% |
| Q2 2025 | $0.03 | -96% |
| Q1 2025 | $0.16 | -91% |
| Q4 2024 | $0.42 | -80% |
CPHC has the edge over F on earnings quality, reporting a profit while its opponent remains loss making.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | — |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.
CPHC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.1M | +4.2% |
| Q2 2026 | $16.2M | +3.2% |
| Q1 2026 | $13.5M | +2.8% |
| Q4 2025 | $12.4M | +3.9% |
| Q3 2025 | $18.3M | -5% |
| Q2 2025 | $15.7M | -3.3% |
| Q1 2025 | $13.1M | -6.8% |
| Q4 2024 | $12M | -4.4% |
CPHC's revenue grew through 2023 and has held roughly level since: $19M last quarter, up 4.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.9% | +3.2 points |
| Q2 2026 | 1.8% | -1 points |
| Q1 2026 | 7.8% | +2.9 points |
| Q4 2025 | 2.6% | +3.5 points |
| Q3 2025 | 5.7% | -13 points |
| Q2 2025 | 2.8% | -4.2 points |
| Q1 2025 | 4.9% | -7.6 points |
| Q4 2024 | -0.8% | -5.5 points |
CPHC has the edge over F on profitability, with a higher operating margin.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F has the edge over CPHC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F's operating margin was 2.9% last quarter, about level with the same quarter a year ago.
CPHC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.7M | +$3.1M |
| Q2 2026 | $3.6M | +11% |
| Q1 2026 | $2.6M | +3.6% |
| Q4 2025 | -$611.3K | +$6.1M |
| Q3 2025 | -$395.3K | -$395.3K |
| Q2 2025 | $3.2M | +78% |
| Q1 2025 | $2.5M | +$3.1M |
| Q4 2024 | -$6.7M | -$5.7M |
CPHC has the edge over F on cash flow, with more consistent year-over-year improvement.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F still generates free cash flow, though less than at its 2020 peak: $5.1B over the past year.
CPHC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +54.4K shares |
| 1 year | +2.1% | +107K shares |
| 3 years | +5.2% | +258K shares |
| 5 years | +8.8% | +422K shares |
| Available history | +13% | +601K shares |
CPHC has 5M diluted shares, up 2.1% from a year ago.
F Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.2% | +89M shares |
| 1 year | +0.7% | +28M shares |
| 3 years | +0.6% | +26M shares |
| 5 years | +1% | +40M shares |
| Available history | +1.8% | +72M shares |
F has the edge over CPHC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $311M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $150M |
F spent $311M buying back its own shares over the past year, up 107% from the year before.
CPHC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.3x | Net Cash |
| Q2 2026 | -2.0x | Net Cash |
| Q1 2026 | -1.8x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -2.0x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.2x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
CPHC has more cash than debt.
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has the edge over CPHC on leverage, with a lower net debt burden relative to earnings.
CPHC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.0 | Neutral |
| Stochastic | 70.6 | Neutral |
CPHC's weekly RSI is 48 (neutral) and its Stochastic is 71 (neutral).
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
CPHC PE vs Consumer Cyclical Sector
| Metric | CPHC | Sector median | Relative |
|---|---|---|---|
| PE | 157x | 18x | 771% above |
| PE % | 92 | 47 | 45 pts above |
CPHC is trading at 157x earnings, a 771% premium to the Consumer Cyclical sector's median of 18x.
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
F has no meaningful PE right now: it lost money over the past year.
CPHC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.8 | 0.3% below |
| 20 week MA | $15.8 | 0.4% below |
| 50 week MA | $15.7 | 0.3% above |
| 100 week MA | $16.9 | 7% below |
| 200 week MA | $19.5 | 19% below |
CPHC has the edge over F on trend strength, trading above more of its moving averages.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.
CPHC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.4 | $12.4 | -0.5% |
| 2021 | $12.4 | $17.6 | +42% |
| 2022 | $17.6 | $28.8 | +64% |
| 2023 | $28.8 | $20.4 | -29% |
| 2024 | $20.4 | $21.9 | +7.2% |
| 2025 | $21.9 | $15.3 | -30% |
| 2026 YTD | $15.3 | $15.7 | +2.5% |
CPHC has the edge over F on returns for 2026, with the stronger performance.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F's yearly returns have swung widely, from +129% in 2021 to −44% in 2022. It's down 11% so far in 2026.